Showing results (111-120 of 292) with videos related to

Sort By:
Pageof 30
The Pediatric Infectious Disease Journal|September 18, 2015
Guillain-BarrÉ Syndrome After Immunization in Canadian Children (1996-2012)Karina A Top, Shalini Desai, Dorothy Moore, et al.
Clinical Trials (London, England)|September 9, 2011
Strategies for successful rapid trials of influenza vaccineDavid W Scheifele, Kim Marty, Carol LaJeunesse, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|December 2, 2010
Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selectionNicole Le Saux, Julie A Bettinger, Susan Wootton, et al.
The Pediatric Infectious Disease Journal|May 14, 2009
Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United StatesDavid P Greenberg, Martha Doemland, Julie A Bettinger, et al.
The Clinical Journal of Pain|July 23, 2015
Pharmacological and Combined Interventions to Reduce Vaccine Injection Pain in Children and Adults: Systematic Review and Meta-AnalysisVibhuti Shah, Anna Taddio, C Meghan McMurtry, et al.
Lancet Regional Health. Americas|March 16, 2022
The effect of the COVID-19 pandemic on influenza-related hospitalization, intensive care admission and mortality in children in Canada: A population-based studyHelen E Groves, Jesse Papenburg, Kayur Mehta, et al.
Vaccine|October 1, 2014
Low pertussis toxin antibody levels in two regional cohorts of Canadian pregnant womenMark Bigham, Stephanie Konrad, Paul Van Buynder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2014
The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012Manish Sadarangani, David W Scheifele, Scott A Halperin, et al.
Human Vaccines & Immunotherapeutics|April 10, 2013
Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine: results of a randomized trialDavid W Scheifele, Marc Dionne, Brian J Ward, et al.
Pediatrics|August 31, 2012
Comparison of children hospitalized with seasonal versus pandemic influenza A, 2004-2009Dat Tran, Wendy Vaudry, Dorothy L Moore, et al.
Pageof 30